Core Viewpoint - Herbalife Ltd. is set to enhance its personalized nutritional supplement capabilities through the planned acquisition of Bioniq, a UK-based company specializing in personalized supplements, which aligns with Herbalife's vision of becoming a technology-enabled health and wellness platform [1][2]. Company Overview - Herbalife Ltd. is a premier health and wellness company that has been providing nutrition products and business opportunities through independent distributors since 1980, operating in over 90 markets [10]. - Bioniq, founded in 2019, focuses on personalized supplements based on individual health data and has developed unique formulas for hundreds of thousands of users [12]. Acquisition Details - The acquisition involves a purchase price of $55 million, to be paid over five years, with an initial payment of $10 million at closing and up to $95 million in contingent payments based on future performance [7]. - The transaction is expected to close in the second quarter of 2026, pending regulatory approvals [7]. Strategic Implications - The acquisition of Bioniq will complement Herbalife's previous acquisitions of Pro2col and Link BioSciences, allowing for a broader range of personalized nutritional supplements and enhancing Herbalife's global manufacturing capabilities [3]. - Herbalife has also secured a call option to acquire Bioniq LAB, which focuses on small molecules and peptides, providing strategic flexibility for future opportunities [8]. Market Expansion - Bioniq's personalized nutritional supplements are anticipated to be available later this year through Herbalife's independent distributors in select countries in Europe and the United States, with plans for further market expansion [9].